BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
51 results:

  • 1. Momordicine-I Suppresses head and neck cancer Growth by Reprogrammimg Immunosuppressive Effect of the Tumor-Infiltrating Macrophages and B Lymphocytes.
    Sur S; Bhartiya P; Steele R; Brennan M; DiPaolo RJ; Ray RB
    Mol Cancer Ther; 2024 May; 23(5):672-682. PubMed ID: 38315993
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Licochalcone A induces G2/M phase arrest and apoptosis via regulating p53 pathways in esophageal cancer: In-vitro and in-vivo study.
    Liu J; Deng L; Wang L; Qian D; He C; Ren Q; Zhang Q; Chen Y
    Eur J Pharmacol; 2023 Nov; 958():176080. PubMed ID: 37758012
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identifying potential immuno-oncology targets in salivary gland mucoepidermoid carcinoma based on inflammatory status and treatment response.
    Urumarudappa SKJ; Tran VNT; Oo HM; Suntiparpluacha M; Sampattavanich S; Rosa V; Ruangritchankul K; Ferreira JN; Chaisuparat R
    J Oral Pathol Med; 2023 Nov; 52(10):939-950. PubMed ID: 37756121
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
    Hoffmann F; Franzen A; de Vos L; Wuest L; Kulcsár Z; Fietz S; Maas AP; Hollick S; Diop MY; Gabrielpillai J; Vogt T; Kuster P; Zarbl R; Dietrich J; Kristiansen G; Brossart P; Landsberg J; Strieth S; Dietrich D
    Clin Epigenetics; 2023 Jul; 15(1):112. PubMed ID: 37415208
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.
    Daroonpan P; Ouchi R; Zhang C; Nagai S; Nishii N; Kashima Y; Tsushima F; Harada H; Hamagaki M; Ikeda T; Aida J; Kaomongkolgit R; Azuma M
    Oral Oncol; 2023 Aug; 143():106458. PubMed ID: 37329869
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in head and neck Squamous Cell Carcinoma.
    Gavrielatou N; Vathiotis I; Aung TN; Shafi S; Burela S; Fernandez AI; Moutafi M; Burtness B; Economopoulou P; Anastasiou M; Foukas P; Psyrri A; Rimm DL
    Cancer Res Commun; 2023 Apr; 3(4):558-563. PubMed ID: 37057033
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
    Shao S; Scholtz LU; Gendreizig S; Martínez-Ruiz L; Florido J; Escames G; Schürmann M; Hain C; Hose L; Mentz A; Schmidt P; Wang M; Goon P; Wehmeier M; Brasch F; Kalinowski J; Oppel F; Sudhoff H
    BMC Cancer; 2023 Jan; 23(1):47. PubMed ID: 36639629
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory head and neck cancer.
    Clubb JHA; Kudling TV; Heiniö C; Basnet S; Pakola S; Cervera Carrascón V; Santos JM; Quixabeira DCA; Havunen R; Sorsa S; Zheng V; Salo T; Bäck L; Aro K; Tulokas S; Loimu V; Hemminki A
    Front Immunol; 2022; 13():794251. PubMed ID: 35355980
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced head and neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.
    Taylor MH; Betts CB; Maloney L; Nadler E; Algazi A; Guarino MJ; Nemunaitis J; Jimeno A; Patel P; Munugalavadla V; Tao L; Adkins D; Goldschmidt JH; Cohen EEW; Coussens LM
    Clin Cancer Res; 2022 Mar; 28(5):903-914. PubMed ID: 34862248
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pharmacological Inhibition of HSP90 Radiosensitizes head and neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Naz S; Leiker AJ; Choudhuri R; Preston O; Sowers AL; Gohain S; Gamson J; Mathias A; Van Waes C; Cook JA; Mitchell JB
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1295-1305. PubMed ID: 33838214
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma.
    Henn TE; Anderson AN; Hollett YR; Sutton TL; Walker BS; Swain JR; Sauer DA; Clayburgh DR; Wong MH
    Head Neck; 2021 Jul; 43(7):2193-2201. PubMed ID: 33835633
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary melanoma of the oral cavity: A multi-institutional retrospective analysis in Brazil.
    Rodrigues BT; Cunha JL; Albuquerque DM; Chagas WP; Freire ND; Agostini M; Canedo NH; Albuquerque Júnior RL; de Sousa SF; Abrahão AC; Romañach MJ; Almeida OP
    Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e379-e386. PubMed ID: 33340079
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
    Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Antibody Supervised Training of a Deep Learning Based Algorithm for Leukocyte Segmentation in Papillary Thyroid Carcinoma.
    Stenman S; Bychkov D; Kucukel H; Linder N; Haglund C; Arola J; Lundin J
    IEEE J Biomed Health Inform; 2021 Feb; 25(2):422-428. PubMed ID: 32750899
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics.
    Krämer M; Plum PS; Velazquez Camacho O; Folz-Donahue K; Thelen M; Garcia-Marquez I; Wölwer C; Büsker S; Wittig J; Franitza M; Altmüller J; Löser H; Schlößer H; Büttner R; Schröder W; Bruns CJ; Alakus H; Quaas A; Chon SH; Hillmer AM
    Mol Oncol; 2020 Jun; 14(6):1170-1184. PubMed ID: 32255255
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
    Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
    J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary Intraosseous Xanthomas of the Jaws: A Series of Six Cases Including an Example with Formation of Apoptosis-Related Hyaline Globules, So-Called "Thanatosomes".
    Wilkinson PE; Merkourea S; Gopalakrishnan R; Argyris PP
    Head Neck Pathol; 2020 Dec; 14(4):859-868. PubMed ID: 31916206
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.
    Weber F; Junger H; Werner JM; Velez Char N; Rejas C; Schlitt HJ; Hornung M
    Cancer Med; 2019 Nov; 8(16):7065-7073. PubMed ID: 31560833
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Proportion and role of cd45+ erythroid progenitor cells in patients with tongue cancer metastasis].
    Wang MQ; Hou M; Lin DP; Wang YG
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jul; 54(7):445-449. PubMed ID: 31288323
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.